Global Pain Therapeutics Market – Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

The neuropathic pain market is the most valuable segment within the pain indications and was valued at $10.8bn in 2020 globally. It is forecast to reach $25.2bn by 2027 at a compound annual growth rate (CAGR) of 12.9%. The launch of different late-stage pipeline products throughout the forecast period will contribute heavily to the growth expected in the neuropathic pain market.

The pain therapeutics market is highly genericized with a wide range of treatment options available for pain indications. There are currently 12,048 marketed pain products globally. Mixed Pain products lead the group with 7,715 products approved, followed by Neuropathic Pain with 5,545 approved drugs and lastly Nociceptive Pain with 4,036 approved products.

The main focus for development in the pipeline is drugs for neuropathic pain indications. There are currently 315 pain therapeutics in development globally. Neuropathic pain therapies lead with 138 pipeline agents, followed by mixed pain and nociceptive pain with 96 and 81 drugs, respectively. The majority of products in development are in Phase II, with 137 products in the pipeline, followed by 106 products in Phase I and 55 in Phase III.

Alessio Brunello, Managing Pharma Analyst at GlobalData, comments: “The Innovation in the pain market over the last decade has been limited to new drug delivery systems, new extended-release formulations, and the repositioning of anticonvulsant and antidepressant therapeutics for difficult-to-treat pain conditions. Despite the improvements in symptom relief offered by new treatments and delivery systems, the pain market still has significant unmet needs. Opioids remain the most effective modes of treatment. However, because of their abuse potential, they are typically administered for chronic pain conditions. Furthermore, there is a significant lack of therapeutics that provide adequate relief for chronic pain types. This has resulted in regulatory changes, with the FDA employing tighter restrictions regarding the prescription and labeling of painkillers, as well as actively encouraging the development of novel analgesics.

“Chronic pain represents one of the most important public health problems in terms of the number of patients afflicted and healthcare cost. Most patients with chronic pain are treated with medications as the mainstay of therapy, yet most medically treated patients continue to report ongoing pain. Existing pain medications have significant limitations and adverse events including tolerance, dependence, gastrointestinal dysfunction, cognitive impairment, and a narrow therapeutic window, making the search for novel analgesics even more important.”


Pain is a multifaceted disorder that can be classified in a multitude of ways. Pain can be classified based on physiology, intensity, temporal characteristics, type of tissue affected, and syndrome. For the scope of this report, GlobalData will use the time course classification, with the main focus on chronic pain.

This report assesses:

– Physician perceptions on Pain Therapeutics usage in clinical practice Globally.

– Global Pain Therapeutics main classes Marketed products and main targets Pipeline products.

– Opportunities and Challenges

– Market analysis and Forecast

– Unmet Needs

– Key Players

The report combines information obtained from secondary sources and primary research with specialists and physicians

GlobalData’s Global Pain Therapeutics Market Overview report combines primary research from a cross-specialty panel of experts with in-house analyst expertise to provide an assessment of the development landscape.

Components of the slide deck include primary and secondary research:

– Quotes from key opinion leaders

– Summary of Pain Therapeutics product definitions and classifications

– Overview of key classes of Pain Therapeutics marketed products and key targets for pipeline Pain products

– Trends in Global Pain Therapeutics market

– Call-outs of key information and details

– Insight from GlobalData’s specialist healthcare analysts

Key Highlights

The Pain Therapeutics Market Is Highly Genericized

The Neuropathic Pain Market Is the Most Valuable Segment Within the Pain Indications

Innovation in the Pain Market Is Limited to New Drug Delivery Systems and New Formulations

The Main Focus for Development in the Pipeline Is Drugs for Neuropathic Pain Indications

Reasons to Buy

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the global Pain Therapeutics.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Pain Therapeutics market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Eli Lilly

Table of Contents

Table of Contents

1. Preface

1.1. Abbreviations

1.2. Related Reports

2. Executive Summary

2.1. Key Findings

3. Pain Overview

3.1. What is Pain?

3.2. Pain Classification

3.3. Acute Pain

3.4. Transitional Pain

3.5. Chronic Pain

4. Trends

4.1. Industry Trends

5. Clinical Trials

5.1. Pain Therapeutics in Clinical Trials

5.2. Pain Therapeutics Clinical Trials by Region

5.3. Pain Therapeutics Clinical Trials by Leading Sponsors

5.4. Pain Therapeutics in Clinical Trials – Challenges

5.5. Pain Therapeutics in Clinical Trials – Opportunities

6. Marketed Products

6.1. Marketed Global Pain Products

6.2. NSAIDs and COX-2 inhibitors

6.3. Opioids

6.4. Antidepressants and Anticonvulsants

7. Pipeline Products

7.1. Global Pain Therapeutics Pipeline Products

7.2. Beta Nerve Growth Factor Target

7.3. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Type I Receptor Target

7.4. Neurotensin Receptor 1 Target

8. Market Analysis

8.1. Mixed Pain Market Analysis and Forecast

8.2. Neuropathic Pain Market Analysis and Forecast

8.3. Nociceptive Pain Market Analysis and Forecast

8.4. Top 10 Deals in the Pain Therapeutics Space

8.5. H1 2021 Deals in the Pain Therapeutics Space

8.6. H2 2020- H1 2021 Mergers and Acquisitions in the Pain Therapeutics Space

9. Opportunities, Challenges, and Unmet Needs

9.1. Global Pain Therapeutics – Opportunities

9.2. Global Pain Therapeutics – Challenges

9.3. Global Pain Therapeutics Unmet Needs – Gap Analysis

10. Key Players

10.1. Pfizer

10.2. Eli Lilly

10.3. Allergan

10.4. Teva

10.5. Viatris

10.6. Novartis

11. Appendix

11.1. Bibliography

11.2. Primary Research

11.3. About the Authors

11.4. About GlobalData

11.5. Contact Us

11.6. Disclaimer

Frequently asked questions

Global Pain Therapeutics Market – Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Global Pain Therapeutics Market – Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Global Pain Therapeutics Market – Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players in real time.

  • Access a live Global Pain Therapeutics Market – Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.